Healthcare Realty Trust (HR) Q3 2024 earnings summary

Executive summary

• Normalized FFO per share was $0.39 for Q3 2024, up 1.2% year-over-year, at the high end of expectations, marking a return to growth.

• Reported a net loss of $93.0 million for Q3 2024, or $(0.26) per diluted share, driven by impairments, credit loss reserves, and a $250.5 million goodwill impairment.

• Over 400,000 sq ft of new leases signed for the fifth consecutive quarter, with multi-tenant absorption and occupancy gains.

• $875 million in proceeds from joint venture and asset sale transactions through October, with share repurchases totaling $447 million year-to-date at an average price of $16.48.

• Leadership changes and realignment were made to support 2025 growth initiatives and enhance operational execution.

Financial highlights

• Same-store property NOI grew 3.1% year-over-year; total multi-tenant NOI growth was 3.5% for the quarter.

• Same-store expenses declined 1.5% year-over-year, supporting NOI growth.

• Cash leasing spreads reached 3.9%, and future contractual escalators for new leases were 3.1%.

• Q3 payout ratio was 106%, or 98% excluding absorption capital; expected to decline below 100% in 2025.

• FFO for Q3 2024 was $170.3 million ($0.47 per share); Normalized FFO was $142.0 million ($0.39 per share).

Outlook and guidance

• 2024 normalized FFO per share guidance narrowed to $1.55–$1.56, including Steward bankruptcy impacts.

• 2024 earnings per share guidance: $(1.59) to $(1.40).

• Core business performance is generating tailwinds for 2025, with expected acceleration in NOI growth as absorption timing normalizes.

• Payout ratio is projected to approach 90% in 2025, adjusted for absorption capital.

• Guidance reflects assumptions on rental rates, occupancy, interest rates, and expenses.